| Value | ₹37.17 Cr |
|---|
NSE filing, NSE: AEGISVOPAK. Summary written from the filing by ALFA Finder's alert engine.
Aegis Vopak Terminals Ltd: key numbers
- Share price
- ₹246.50
- Market cap
- ₹27,312 Cr
- Revenue (annual)
- ₹923.1 Cr
- Net profit (annual)
- ₹310.5 Cr
- P/E (TTM)
- 96.6×Sector 29.0×
- Promoter holding
- 86.93%+0.00% QoQ
- FII holding
- 5.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aegis Vopak Terminals Ltd
All →Aegis Vopak Terminals Q2 FY27 Results: Net Profit ₹96.4 Cr, Down 3.8% YoY
Aegis Vopak Terminals Ltd reported revenue from operations of ₹270.8 Cr (+16.6% YoY) and net profit of ₹96.4 Cr (-3.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹96.4 Cr · -3.8% YoY
Aegis Vopak Terminals Board Meeting Date
Aegis Vopak Terminals Limited scheduled a board meeting for October 26, 2026, to approve its unaudited financial results for the quarter ended September 30, 2026.
Aegis Vopak Terminals Other Announcement
Aegis Vopak Terminals Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026. This filing is a routine disclosure of shareholding data.
Aegis Vopak Terminals Debt & Borrowing: ₹440.2 Cr
Aegis Vopak Terminals will exercise its call option to redeem 44,000 secured NCDs on 9 November 2026. The total redemption, including accrued interest, is ₹440.17 Crore.
- Value
- ₹440.2 Cr
Aegis Vopak Terminals Debt & Borrowing
Aegis Vopak Terminals Limited announced October 23, 2026, as the record date for interest payment on its Non-Convertible Debentures.
Aegis Vopak Terminals Debt & Borrowing
Aegis Vopak Terminals Limited submitted its half-yearly statement of outstanding Non-Convertible Debentures (NCDs) as per SEBI regulations. The filing provides details on current debt ISINs.
Other business update announcements
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years
Msafe Equipments Business Update
MSAFE Equipments announced a Dhanteras puja at its upcoming Mathura integrated manufacturing facility, expected to commence operations by May 2027. The release describes planned capacity expansion but reports no contract, order, or financial value.
Skyways Air Services Business Update
Skyways Air Services renewed its Global Annual Agreement with Qatar Airways for one year. The agreement's size is not quantifiable, so no value is assigned.
- From
- Qatar Airways Group Q.C.S.C.
- Execution
- 1 year from effective date 1 January 2026
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.